The Application of Contrast-Enhanced 3D-STIR-VISTA MR Imaging of the Brachial Plexus.

Objective: To introduce contrast-enhanced 3D-STIR-VISTA sequence that would improve the image quality for the brachial plexus imaging and enhance the contrast between the brachial plexus and surrounding tissues.

Methods: Thirty subjects (average age, 47.33 ± 15.15 years; 22 males and 8 females) were enrolled, including 7 patients with brachial plexus injuries, 4 patients with schwannomas, 1 patient with neurofibroma, 1 patient with thoracic outlet syndrome, 1 patient with metastasis, 1 patient with brachial plexus neuritis, and 15 patients without abnormal findings. Scores of unenhanced and contrast-enhanced 3D-STIR-VISTA images using a 5-point scale were compared by Wilcoxon's signed-rank test. The signal intensity (SI), signal to noise ratio (SNR), contrast to noise ratio (CNR) and contrast ratio (CR) between 3D-STIR-VISTA images without and with contrast agent were compared by the paired Student t-test.

Results: The SNRs of the brachial plexus between 3D-STIR-VISTA without and with contrast agent were not significantly different, while SNRs of surrounding tissues were significantly decreased with contrast agent. The CNRs of 3D-STIR-VISTA images with contrast agent were significantly higher than that without contrast agent. The 3D-STIR-VISTA sequence with contrast agent exhibited a statistically higher CR than that without contrast agent. The average score for 3D-STIR-VISTA images with contrast agent was significantly higher than that without contrast agent.

Conclusion: The 3D-STIR-VISTA sequence with contrast agent is qualitatively and quantitatively superior to that without a contrast agent. The contrast-enhanced 3D-STIR-VISTA sequence can provide distinct visualization of the brachial plexus and enhance the contrast between the brachial plexus and surrounding tissues.